Genetically modified human CD4+ T cells can be evaluated in vivo without lethal graft-versus-host disease

Riyasat Ali, Jeffrey Babad, Antonia Follenzi, John A. Gebe, Michael A. Brehm, Gerald T. Nepom, Leonard D. Shultz, Dale L. Greiner, Teresa P. DiLorenzo

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Genetically modified human CD4<sup>+</sup> T cells can be evaluated in vivo without lethal graft-versus-host disease'. Together they form a unique fingerprint.

Medicine & Life Sciences